http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103833857-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 2014-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103833857-B |
titleOfInvention | A kind of recombination fusion protein hIFN γ-MAP30 and preparation method and application |
abstract | The invention discloses a kind of recombination fusion protein hIFN γ-MAP30 and preparation method and application, hIFN γ and MAP30 is connected together by connection peptides, construct a kind of genetic engineering bacterium of expressing hIFN γ-MAP30 fusion rotein, intestinal bacteria <i>Escherichia? coli? </i>BL21 (DE3) – pET-15b-hIFN γ-MAP30, CCTCC? NO:M2013545.The present invention utilizes E. coli system to produce hIFN γ-MAP30, not only expression amount is large for the hIFN γ-MAP30 fusion rotein obtained, simple to operate, cost is low, also has antibacterial, antiviral, the antitumor action strengthening independent interferon-gamma and independent bitter melon protein MAP30.Intestinal bacteria are non-pathogenic microorganisms simultaneously, there is not the danger of loose poison. |
priorityDate | 2014-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.